Image-guided therapy
Coronary suite
Transforming complex PCI procedures into confident cardiac care
Philips' coronary artery disease (CAD) solutions consist of advanced clinical and workflow applications, therapeutic and diagnostic devices, and leading services, working together to efficiently support every step of coronary procedures. From diagnosis to restoring vessel patency, the coronary suite ecosystem is designed to enhance performance and efficiency, helping clinicians focus time on what matters most.
Improving cath lab performance while giving back time to clinicians
Navigating the cath lab environment can be complex, and having a clear approach is important. Philips offers an integrated ecosystem designed to support your workflow and provide timely insights. This can help improve efficiency and assist with the goal of exceptional patient care. Our CAD solutions are developed to work together, aiming to support quick diagnosis and coordinated treatment—helping you focus on delivering the best possible outcomes.
Azurion 7 M12 - the heart of our solution for cardiac care
Elevate your interventional cardiology capabilities with the Azurion 7 with 12'' flat detector. This high performance image-guided therapy solution allows interventional teams to perform challenging cardiac interventions. Seamlessly control all relevant applications at tableside for a consistent user experience, excellent lab performance and patient care.
Dynamic Coronary Roadmap - real-time coronary guidance
Dynamic Coronary Roadmap provides real-time, automatic, motion-compensated coronary imaging for live guidance of wires and intra-coronary devices, and has been proven to reduce contrast agent usage by 28.8% [3]
IntraSight - when every tiny move matters
Philips IntraSight offers you a comprehensive suite of clinically proven[4-8] imaging, physiology and co-registration[9] tools on a modern, secure platform that will help you simplify complex interventions, speed routine procedures and improve lab efficiencies.
Enabling technologies for Coronary suite
Related procedures
Footnotes
- Coronary IVUS Technologies Intravascular imaging improves outcomes and reduces death Stone G, et al. Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis. Published Online February 21, 2024 https://app.contentful.com/spaces/fzjlyokyl1wq/environments/master/entries/5H9mL1ltYniTWMm296g289
- Philips whitepaper 12nc 4522 991 30501;Reduction of procedure time by 17% with Philips Azurion in independently verified study; Philips Azurion Lab Performance Study. Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions.
- Dynamic Coronary Roadmap versus standard angiography for percutaneous coronary intervention: the randomised, multicentre DCR4 Contrast trial www.documents.philips.com/assets/20240219/0e2a77c4a6904c6eaae3b11b00df6861.pdf
- Davies JE, et al., DEFINE-FLAIR: A Multi- Centre, Prospective, International, Randomized, Blinded Comparison of Clinical Outcomes and Cost Efficiencies of iFR and FFR Decision-Making for Physiological Guided Coronary Revascularization. New England Journal of Medicine, epub March 18, 2017.
- Gotberg M, et al., Instantaneous Wave-Free Ratio Versus Fractional Flow Reserve Guided Intervention (IFR-SWEDEHEART): A Multicenter, Prospective, Registry-Based Randomized Clinical Trial. New England Journal of Medicine, epub March 18, 2017.
- Patel M. “Cost-effectiveness of instantaneous wave-Free Ratio (iFR) compared with Fractional Flow Reserve (FFR) to guide coronary revascularization decision-making.” Late-breaking Clinical Trial presentation at ACC on March 10, 2018.
- A. Maehara, M. Matsumura, Z.A. Ali, G.S. Mintz, G.W. Stone. IVUS-guided versus OCT-guided coronary stent implantation. J Am Coll Cardiol Img, 10 (2017), pp. 1487- 1503.
- Choi K, et al. Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures. JACC: Cardiovascular Interventions. Mar 2019, 4281; DOI: 10.1016/j.jcin.2019.01.227.
- Co-registration tools available within IntraSight 7 configuration via SyncVision
Disclaimer
Always read the label and follow the directions for use.
Philips medical devices should only be used by physicians and teams trained in interventional techniques, including training in the use of this device.
Products subject to country availability. Please contact your local sales representative.
Trademarks are the property of Koninklijke Philips N.V. or their respective owners. Philips reserves the right to change product specifications without prior notification.